The table below shows Corbus Pharmaceuticals Holdings, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$25.57M
-$16.42M
-$7.97M
-$15.11M
-$10.62M
-$21.81M
Capital expenditure
$6.00K
$0.00
-
$0.00
$13.45K
-
Investing cash flow
$22.45M
$18.12M
-$98.24M
$5.55M
$42.96M
-$57.42M
Dividends paid
-
-
-
-
CRBP operating cash flow (10-K history)
Corbus Pharmaceuticals Holdings, Inc. reported operating cash flow of -$64.49M for fiscal year 2025. That is down 54.3% from -$41.79M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$27.80M (FY 2017) to -$64.49M. Figures come from the company's audited annual reports as filed with the SEC.